Research and Development

1 in 3 (36%) of GPs and 1 in 4 (25%) of specialists surveyed were also looking to pursue a …

Karuna Therapeutics has announced positive topline results from its Phase III EMERGENT-2 trial, evaluating the efficacy, safety, and tolerability of …

Tagrisso and Hutchmed have revealed positive Phase II data on their combination drug, which prompts the two partners to progress …

PCI has announced a significant expansion of its facility in Tredegar, Wales, UK, designed to help keep up to date …

Micronesia’s first outbreak of COVID-19 has grown in one week to over 1,000 cases, causing significant alarm in the Pacific …

New NICE guidance has been released, recommending the routine use of placental growth factor (PIGF), based on testing in the …

A major review has found “no clear evidence” that low serotonin levels are responsible for depression. Reviewing existing studies, researchers …

All those aged 50 and over will be offered a COVID-19 booster vaccine this autumn, to top up their immunity …

According to new analysis, the NHS in England could face a shortfall of almost 40,000 nurses by 2024, and under …

TSB Therapeutics has entered a collaboration with China Resources Pharmaceutical Commercial Group (CR Pharma) for the commercialisation of an antibody …

Verve therapeutics has dosed the first patient win its heart-1 clinical trial, studying the safety and efficacy of its in …

The FDA has accepted Byondis’ submission of a Biologics License Application (BLA) for [vic-] trastuzumab duocarmazine (SYD985) in patients with …

The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, has launched an early-stage …

Leading sexual health organisations have warned that monkeypox could become endemic in the UK if the government does not take …

Steve Barclay former chief of staff at Number 10 Downing Street, has been appointed new Health Secretary, following the resignation …